IL146460A0 - 4-phenyl-pyrimidine derivatives - Google Patents
4-phenyl-pyrimidine derivativesInfo
- Publication number
- IL146460A0 IL146460A0 IL14646000A IL14646000A IL146460A0 IL 146460 A0 IL146460 A0 IL 146460A0 IL 14646000 A IL14646000 A IL 14646000A IL 14646000 A IL14646000 A IL 14646000A IL 146460 A0 IL146460 A0 IL 146460A0
- Authority
- IL
- Israel
- Prior art keywords
- phenyl
- pyrimidine derivatives
- pyrimidine
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99110483 | 1999-05-31 | ||
PCT/EP2000/004701 WO2000073279A1 (en) | 1999-05-31 | 2000-05-24 | 4-phenyl-pyrimidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
IL146460A0 true IL146460A0 (en) | 2002-07-25 |
Family
ID=8238271
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14646000A IL146460A0 (en) | 1999-05-31 | 2000-05-24 | 4-phenyl-pyrimidine derivatives |
IL146460A IL146460A (en) | 1999-05-31 | 2001-11-12 | Derivatives of 4-phenyl-pyrimidine |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL146460A IL146460A (en) | 1999-05-31 | 2001-11-12 | Derivatives of 4-phenyl-pyrimidine |
Country Status (36)
Country | Link |
---|---|
US (1) | US6274588B1 (tr) |
EP (1) | EP1187815B1 (tr) |
JP (1) | JP3590592B2 (tr) |
KR (1) | KR100440106B1 (tr) |
CN (1) | CN1166643C (tr) |
AR (1) | AR024146A1 (tr) |
AT (1) | ATE317389T1 (tr) |
AU (1) | AU770786B2 (tr) |
BR (1) | BR0011127A (tr) |
CA (1) | CA2375671C (tr) |
CO (1) | CO5170520A1 (tr) |
CZ (1) | CZ20014271A3 (tr) |
DE (1) | DE60025918T2 (tr) |
DK (1) | DK1187815T3 (tr) |
ES (1) | ES2257294T3 (tr) |
GC (1) | GC0000191A (tr) |
HK (1) | HK1046528B (tr) |
HR (1) | HRP20010871A2 (tr) |
HU (1) | HUP0201315A3 (tr) |
IL (2) | IL146460A0 (tr) |
JO (1) | JO2261B1 (tr) |
MA (1) | MA26793A1 (tr) |
MX (1) | MXPA01012089A (tr) |
MY (1) | MY122731A (tr) |
NO (1) | NO321354B1 (tr) |
NZ (1) | NZ515407A (tr) |
PE (1) | PE20010153A1 (tr) |
PL (1) | PL353441A1 (tr) |
PT (1) | PT1187815E (tr) |
RU (1) | RU2243221C2 (tr) |
SI (1) | SI1187815T1 (tr) |
TR (1) | TR200103457T2 (tr) |
TW (1) | TW550258B (tr) |
WO (1) | WO2000073279A1 (tr) |
YU (1) | YU84901A (tr) |
ZA (1) | ZA200109163B (tr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ514600A0 (en) | 2000-01-18 | 2000-02-10 | James Cook University | Brain injury treatment |
EP1318147A1 (en) * | 2000-09-14 | 2003-06-11 | Ajinomoto Co., Inc. | Novel pyrimidine derivative and novel pyridine derivative |
MXPA03007395A (es) * | 2001-02-20 | 2003-12-04 | Bristol Myers Squibb Co | Derivados de pirimidin-5-carboxamida 2,4-disustituida como moduladores del canal de potasio kcnq. |
EP1679309A4 (en) * | 2003-10-24 | 2007-03-28 | Ono Pharmaceutical Co | ANTISTRESS MEDICAMENT AND ITS MEDICAL USE |
HUP0400405A3 (en) * | 2004-02-10 | 2009-03-30 | Sanofi Synthelabo | Pyrimidine derivatives, process for producing them, their use, pharmaceutical compositions containing them and their intermediates |
JP2008519034A (ja) | 2004-11-03 | 2008-06-05 | バーテックス ファーマシューティカルズ インコーポレイテッド | イオンチャネル調節剤としてのピリミジン誘導体および使用方法 |
ES2329827T3 (es) * | 2005-02-22 | 2009-12-01 | F. Hoffmann-La Roche Ag | Antagonistas de nk1. |
EP2281556A1 (en) | 2005-02-25 | 2011-02-09 | F. Hoffmann-La Roche AG | Tablets with improved drugs substance dispersibility |
CA2612227C (en) * | 2005-06-14 | 2014-04-22 | Taigen Biotechnology Co., Ltd. | Pyrimidine compounds |
US8372849B2 (en) | 2008-04-21 | 2013-02-12 | Taigen Biotechnology Co., Ltd. | Heterocyclic compounds |
US8580805B2 (en) * | 2010-08-31 | 2013-11-12 | Hubert Maehr | Pyrimidine carboxamide derivatives |
EP3250034B1 (en) * | 2015-01-30 | 2020-03-11 | Basf Se | Herbicidal phenylpyrimidines |
KR102335082B1 (ko) * | 2017-01-10 | 2021-12-06 | 내셔날 헬스 리서치 인스티튜트 | 헤테로사이클릭 화합물 및 이의 용도 |
KR102006547B1 (ko) * | 2017-11-16 | 2019-08-01 | 서울대학교산학협력단 | 벤즈아미드 유도체 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 염증질환의 치료 또는 예방용 약학적 조성물 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4698340A (en) | 1984-07-19 | 1987-10-06 | Fujisawa Pharmaceutical Co., Ltd. | Pyrimidine derivatives, processes for preparation thereof and composition containing the same |
DE3614060A1 (de) * | 1986-04-23 | 1987-10-29 | Schering Ag | Pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide |
US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
ATE278687T1 (de) | 1993-12-29 | 2004-10-15 | Merck Sharp & Dohme | Substituierte morpholinderivate und ihre verwendung als therapeutische mittel |
JPH11512399A (ja) | 1995-09-01 | 1999-10-26 | シグナル ファーマシューティカルズ,インコーポレイテッド | ピリミジンカルボキサミドおよび関連化合物ならびに炎症状態を処置するための方法 |
US5972938A (en) | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
-
2000
- 2000-05-22 TW TW089109829A patent/TW550258B/zh not_active IP Right Cessation
- 2000-05-22 US US09/575,382 patent/US6274588B1/en not_active Expired - Fee Related
- 2000-05-24 DE DE60025918T patent/DE60025918T2/de not_active Expired - Fee Related
- 2000-05-24 RU RU2001133458/04A patent/RU2243221C2/ru not_active IP Right Cessation
- 2000-05-24 IL IL14646000A patent/IL146460A0/xx active IP Right Grant
- 2000-05-24 AT AT00927234T patent/ATE317389T1/de not_active IP Right Cessation
- 2000-05-24 DK DK00927234T patent/DK1187815T3/da active
- 2000-05-24 NZ NZ515407A patent/NZ515407A/xx unknown
- 2000-05-24 SI SI200030813T patent/SI1187815T1/sl unknown
- 2000-05-24 BR BR0011127-9A patent/BR0011127A/pt not_active Application Discontinuation
- 2000-05-24 JP JP2000621345A patent/JP3590592B2/ja not_active Expired - Fee Related
- 2000-05-24 CA CA002375671A patent/CA2375671C/en not_active Expired - Fee Related
- 2000-05-24 EP EP00927234A patent/EP1187815B1/en not_active Expired - Lifetime
- 2000-05-24 TR TR2001/03457T patent/TR200103457T2/tr unknown
- 2000-05-24 CZ CZ20014271A patent/CZ20014271A3/cs unknown
- 2000-05-24 WO PCT/EP2000/004701 patent/WO2000073279A1/en active IP Right Grant
- 2000-05-24 ES ES00927234T patent/ES2257294T3/es not_active Expired - Lifetime
- 2000-05-24 MX MXPA01012089A patent/MXPA01012089A/es active IP Right Grant
- 2000-05-24 CN CNB008082758A patent/CN1166643C/zh not_active Expired - Fee Related
- 2000-05-24 PT PT00927234T patent/PT1187815E/pt unknown
- 2000-05-24 AU AU45677/00A patent/AU770786B2/en not_active Ceased
- 2000-05-24 PL PL00353441A patent/PL353441A1/xx unknown
- 2000-05-24 KR KR10-2001-7015393A patent/KR100440106B1/ko not_active IP Right Cessation
- 2000-05-24 YU YU84901A patent/YU84901A/sh unknown
- 2000-05-24 HU HU0201315A patent/HUP0201315A3/hu unknown
- 2000-05-26 PE PE2000000508A patent/PE20010153A1/es not_active Application Discontinuation
- 2000-05-28 JO JO200083A patent/JO2261B1/en active
- 2000-05-29 MY MYPI20002384A patent/MY122731A/en unknown
- 2000-05-29 CO CO00039590A patent/CO5170520A1/es not_active Application Discontinuation
- 2000-05-29 AR ARP000102643A patent/AR024146A1/es not_active Application Discontinuation
- 2000-05-30 GC GCP2000684 patent/GC0000191A/en active
-
2001
- 2001-11-06 ZA ZA200109163A patent/ZA200109163B/en unknown
- 2001-11-12 IL IL146460A patent/IL146460A/en not_active IP Right Cessation
- 2001-11-22 NO NO20015700A patent/NO321354B1/no unknown
- 2001-11-22 HR HR20010871A patent/HRP20010871A2/hr not_active Application Discontinuation
- 2001-11-26 MA MA26424A patent/MA26793A1/fr unknown
-
2002
- 2002-10-22 HK HK02107643.4A patent/HK1046528B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
HUP0201535A2 (en) | 5-cyano-2-aminopyrimidine derivatives | |
IL148167A0 (en) | Amino-triazolopyridine derivatives | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
IL145739A0 (en) | 13-methyl-erythromycin derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
IL148837A0 (en) | Isoxazolecarboxamide derivatives | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
IL150132A0 (en) | Cyclopenteneone derivatives | |
IL147636A0 (en) | 3-amino-2-benzyl-1-phenyl-propane derivatives | |
GB0026485D0 (en) | ›-Carboline derivatives | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
AP2001002327A0 (en) | 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives | |
PL351407A1 (en) | Thio-oxindole derivatives | |
IL146282A0 (en) | Thio-oxindole derivatives | |
GB9907134D0 (en) | Antimor napthylcombretastatin derivatives | |
SI1200445T1 (en) | Thienopyranecarboxamide derivatives | |
SI1226131T1 (en) | Isoxazolecarboxamide derivatives | |
HK1043987A1 (zh) | 硫-羥吲衍生物 | |
SI1178984T1 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |